JPMORGAN CHASE & CO - BRIDGEBIO PHARMA INC ownership

Back to all holdings Add to watchlist

BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806X952. A total of 4 filers reported holding BRIDGEBIO PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q2 2023$407,640
+206.5%
23,700
+196.2%
0.00%–
Q1 2023$133,000
-89.7%
8,000
-89.7%
0.00%–
Q4 2021$1,291,000–77,400–0.00%–
 Download
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 174,600$4,604,2020.02%
SIMPLEX TRADING, LLC 282,300$7,4440.01%
JANE STREET GROUP, LLC 118,300$3,119,5710.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BRIDGEBIO PHARMA INC shareholders